Orthofix's spine fixation sales jump 17.1% in Q2 2017 — 7 highlights

Written by Megan Wood | August 08, 2017 | Print  |

Orthofix International reported its second quarter financial results for 2017.

Here are seven highlights:

 

1. The company saw net sales of $108.9 million, reflecting a 4.7 percent increase over the same period the year prior.

 

2. Biologic sales jumped 9.9 percent to $15.7 million, compared to the second quarter of 2016.

 

3. Orthofix's spine fixation sales hit $21.4 million, a 17.1 percent increase over the second quarter of 2016.

 

4. The company's gross profit increased to $85.8 million over the year prior.

 

5. Net income from continuing operations hit $4.7 million, or $0.26 per share.

 

6. Orthofix's EBITDA was $14 million in the second quarter of 2017, up from $2.6 million in the same period the year prior.

 

7. The company's cash and cash equivalents were $44.3 million as of June 30.

 

More articles on devices:
K2M, Smith & Nephew & more: 9 device company mergers, acquisitions and agreements
RTI Surgical reports $72.1M in Q2 revenue: 5 highlights
DePuy Synthes & Medical Enterprises Distribution to co-market automated THA technology: 6 points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months